Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer—clinical aspects and relationship with tumour response: a single-centre prospective cohort studyMarie Kostine, Thierry Schaeverbeke, L. Rouxel et al.|Annals of the Rheumatic Diseases|2017Cited by 302
Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: A systematic review and meta-analysisL. Legendre, C. Paul, Thomas Barnetche et al.|Journal of the American Academy of Dermatology|2015Cited by 204
Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse eventsMarie Kostine, Thierry Schaeverbeke, Eleonora Mauric et al.|European Journal of Cancer|2021Cited by 93
Predictive biological markers of systemic lupus erythematosus flares: a systematic literature reviewChristophe Richez, Noémie Gensous, A. Marti et al.|Arthritis Research & Therapy|2017Cited by 92
Immunogenicity and impact on disease activity of influenza and pneumococcal vaccines in systemic lupus erythematosus: a systematic literature review and meta-analysisMathilde Pugès, P. Duffau, P. Biscay et al.|Lara D. Veeken|2016Cited by 80